Our partners are vital in our process. Together the team has been commercializing medical device technology for over 60 years. The group is expert at market and technical analysis, development of patentable IP, clinical trials, project management and exit through trade sales and IPOs. Our companies benefit from the increased exposure to those partners during the incubation phase. On the other hand, our investors and advisors know what is needed for a successful A round financing or early stage corporate deal, and are critical in assisting with decision-making. Once a larger number of deal opportunities have been triaged through a thorough and repeatable process, we select only the best for investment. MD Start then closely manages those investments, leading the company through proof of concept stage.